ZEJULA (TESARO, Inc.)
Welcome to the PulseAid listing for the ZEJULA drug offered from TESARO, Inc.. This Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | TESARO, Inc. |
| NON-PROPRIETARY NAME: | niraparib |
| SUBSTANCE NAME: | NIRAPARIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-03-27 |
| END MARKETING DATE: | 0000-00-00 |
ZEJULA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZEJULA from TESARO, Inc. |
| LABELER NAME: | TESARO, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2017-03-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69656-103_25800645-58e8-451e-821f-f9d5a190428d |
| PRODUCT NDC: | 69656-103 |
| APPLICATION NUMBER: | NDA208447 |
Other NIRAPARIB Pharmaceutical Manufacturers / Labelers:
